Scientific illustration depicting the TMEM175 lysosomal ion channel preventing over-acidification and toxic buildup in neurons, relevant to Parkinson’s disease research.
Scientific illustration depicting the TMEM175 lysosomal ion channel preventing over-acidification and toxic buildup in neurons, relevant to Parkinson’s disease research.
AI에 의해 생성된 이미지

Study links lysosomal ion channel TMEM175 to protection against over-acidification, with implications for Parkinson’s research

AI에 의해 생성된 이미지
사실 확인됨

Researchers at LMU Munich, Bonn-Rhein-Sieg University of Applied Sciences, TU Darmstadt and Nanion Technologies report that the lysosomal ion channel TMEM175 helps prevent excessive acidification inside lysosomes, a malfunction that the team says could contribute to toxic buildup associated with Parkinson’s disease. The findings were reported in the Proceedings of the National Academy of Sciences.

A team from Bonn-Rhein-Sieg University of Applied Sciences (H-BRS), Ludwig Maximilian University of Munich (LMU Munich), TU Darmstadt and Nanion Technologies has reported new evidence clarifying how the lysosomal ion channel TMEM175 influences acidity in lysosomes—membrane-bound compartments that break down cellular waste.

Lysosomes need an acidic interior to degrade macromolecules into reusable building blocks. According to the researchers, this acidity is generated by a protein that pumps protons (H+) into lysosomes, while additional proteins in the lysosomal membrane help keep the pH within an optimal range.

In a study described by LMU Munich in a university news release and reposted by ScienceDaily, the scientists say TMEM175 acts as an “overflow valve” that helps prevent lysosomes from becoming too acidic. The release says the work addresses a long-running debate over whether TMEM175 primarily conducts potassium ions or protons, reporting that the channel can conduct both and that its behavior changes depending on luminal acidity.

The collaboration was led by pharmacologist Professor Christian Grimm (LMU Munich) and Dr. Oliver Rauh (H-BRS), according to the same release. The researchers said they relied largely on patch-clamp measurements—an electrophysiology method used to characterize ion flow through channels—to show that TMEM175 can sense when lysosomal acidity reaches a critical state and adjust proton flow through the channel.

In the release, Rauh is quoted as saying the study establishes a “decisive” role for TMEM175 in this process and calling the protein unusual among ion channels. “We’ve now been able to demonstrate that TMEM175 not only conducts potassium ions, but also protons, and is thus directly involved in the regulation of pH … in the interior of lysosomes,” he said.

The researchers also argued that mutations affecting TMEM175 can disrupt pH regulation and impair lysosomal degradation, potentially contributing to toxic protein buildup and neuronal cell death. The news release links these effects to Parkinson’s disease and other neurodegenerative conditions and describes TMEM175 as a potential target for drug development.

The study was published in the Proceedings of the National Academy of Sciences under the title “Proton-selective conductance and gating of the lysosomal cation channel TMEM175,” with the DOI 10.1073/pnas.2503909123, and a publication date of January 14, 2026.

관련 기사

Scientific illustration depicting healthy and damaged tanycytes in the brain's third ventricle clearing tau protein in Alzheimer’s disease.
AI에 의해 생성된 이미지

Study links tanycyte damage to reduced tau clearance in Alzheimer’s disease

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

Researchers report that tanycytes—specialized cells lining the brain’s third ventricle—can help move tau protein from cerebrospinal fluid into the bloodstream, and that signs of tanycyte disruption in Alzheimer’s patient tissue may be associated with impaired tau removal. The findings, published March 5 in Cell Press Blue, are based on animal and cell experiments and analyses of human brain samples.

Researchers at UCLA Health and UC San Francisco have identified a natural defense mechanism in brain cells that helps remove toxic tau protein, potentially explaining why some neurons resist Alzheimer's damage better than others. The study, published in Cell, used CRISPR screening on lab-grown human neurons to uncover this system. Findings suggest new therapeutic avenues for neurodegenerative diseases.

AI에 의해 보고됨

Researchers at Cold Spring Harbor Laboratory have found that blocking the protein PTP1B improves memory and boosts plaque clearance in mouse models of Alzheimer's disease. The discovery links the protein to brain immune function and metabolic risks like diabetes and obesity. The team aims to develop inhibitors for potential human treatments.

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부